Relationship between serum and sol secretory leukoprotease inhibitor (SLPI) during exacerbations of chronic bronchitis

A. Sullivan, D. Bayley, C. O‘Brien, S. Gompertz, R. Stockley (Birmingham, United Kingdom)

Source: Annual Congress 2006 - Cell biology of asthma and COPD
Session: Cell biology of asthma and COPD
Session type: Oral Presentation
Number: 4612
Disease area: Airway diseases, Respiratory infections

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
A. Sullivan, D. Bayley, C. O‘Brien, S. Gompertz, R. Stockley (Birmingham, United Kingdom). Relationship between serum and sol secretory leukoprotease inhibitor (SLPI) during exacerbations of chronic bronchitis. Eur Respir J 2006; 28: Suppl. 50, 4612

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Imbalance between leukoprotease inhibitor levels and neutrophils in BAL from smokers with chronic bronchitis and recurrent exacerbations
Source: Eur Respir J 2001; 18: Suppl. 33, 66s
Year: 2001

Increased serum concentration of urinary trypsin inhibitor with asthma exacerbation
Source: Eur Respir J 2003; 22: 739-742
Year: 2003



The effect of sputum processing on tumour necrosis factor (TNFα), secretory leukoprotease inhibitor (SLPI), interleukin-6 and leukotriene-B4 (LTB4) in chronic bronchitis and bronchiectasis
Source: Eur Respir J 2001; 18: Suppl. 33, 364s
Year: 2001

Effect of recombinant α-1 antitrypsin (rAAT) and TAPI on neutrophil elastase (NE) and matrix metalloproteinase-9 (MMP9) activity in induced sputum (IS) from healthy smokers and patients with chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2003 - Progress on therapy for chronic obstructive pulmonary disease
Year: 2003


Proteinase 3 activity in sputum from subjects with alpha-1-antitrypsin deficiency and COPD
Source: Eur Respir J 2013; 41: 1042-1050
Year: 2013



Increased serum concentrations of tissue inhibitor of metalloproteinase-1 in COPD patients
Source: Eur Respir J 2005; 25: 885-890
Year: 2005



Relationship between MMP-9 and TIMP-1 induced sputum concentration and the stage of chronic obstructive pulmonary disease‘s (COPD)
Source: Annual Congress 2008 - Issues in the management of COPD in the community
Year: 2008

Serum surfactant protein D is steroid sensitive and associated with exacerbations of COPD
Source: Eur Respir J 2009; 34: 95-102
Year: 2009



Relationship between mucociliary clearance‘s (MCC) disorders and proteinase activity of sputum in patients with COPD
Source: Annual Congress 2007 - Clinical aspects of COPD II
Year: 2007


Decreased levels of secretory leucoprotease inhibitor in the pseudomonas-infected cystic fibrosis lung are due to neutrophil elastase degradation
Source: Annual Congress 2009 - Airway inflammation and host defence
Year: 2009


Elevation of neutrophil collagenase (MMP-8) and elastase during COPD exacerbation
Source: Annual Congress 2008 - Inflammatory trigger mechanisms in asthma and COPD
Year: 2008


Bacterial infection, IL-8 and elastase activity in children with chronic bronchiolitis and bronchial asthma in stable period
Source: Eur Respir J 2003; 22: Suppl. 45, 516s
Year: 2003

Role of secretory leukocyte protease inhibitor in the development of subclinical emphysema
Source: Eur Respir J 2002; 19: 1050-1057
Year: 2002



Neutrophil elastase in severe COPD and asthma exacerbation
Source: Eur Respir J 2006; 28: Suppl. 50, 36s
Year: 2006

Interleukin-13 and -4 expression in the central airways of smokers with chronic bronchitis
Source: Eur Respir J 2003 Oct 01;22(4):602-608
Year: 2003



Relationship between sputum level of matrix metallopreteinase (MMP-9)/tissue inhibitor of metalloproteinase (TIMP-1) and methacholine bronchial hyper-reactivity in asthma
Source: Eur Respir J 2005; 26: Suppl. 49, 733s
Year: 2005

Secretory leukoprotease inhibitor (SLPI) is removed from media of primary bronchial epithelial cells (PBEC) in the presence of neutrophil elastase (NE)
Source: Eur Respir J 2005; 26: Suppl. 49, 554s
Year: 2005

A functional variant of secretory leukocyte protease inhibitor (SLPI) with improved anti-inflammatory activity against pulmonary infection
Source: Lung Science Conference 2015
Year: 2015

Inhibiting effect of influenza vaccinations on serum eotaxin level in patients with allergic bronchial asthma and chronic obstructive pulmonary disease
Source: Eur Respir J 2004; 24: Suppl. 48, 134s
Year: 2004

MMP2, 8, 9 and TIMP1-4 levels in bronchoalveolar fluid of patients with chronic obstructive pulmonary disease and bronchial asthma
Source: Annual Congress 2010 - Mechanisms and modulation of allergic inflammation in the lung
Year: 2010